Exact Mass: 476.1503
Exact Mass Matches: 476.1503
Found 137 metabolites which its exact mass value is equals to given mass value 476.1503,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Temocapril
alpha-((2S,6R)-6-((1S)-1-Ethoxycarbonyl-3-phenylpropyl)amino-5-oxo-2-(2-thienyl)perhydro-1,4-thiazepin-4-yl)acetic acid.hcl
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain Temocapril belongs to the class of organic compounds known as alpha amino acid esters. These are ester derivatives of alpha amino acids. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Bapta
2-{[2-(2-{2-[bis(carboxymethyl)amino]phenoxy}ethoxy)phenyl](carboxymethyl)amino}acetic acid
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D064449 - Sequestering Agents > D002614 - Chelating Agents BAPTA is a selective chelator for calcium. BAPTA, as calcium indicator, has high selectivity against magnesium and calcium. BAPTA is widely used as an intracellular buffer for investigating the effects of Ca2+ release from intracellular stores or influx via Ca2+-permeable channels in the plasma membrane. BAPTA can also inhibit phospholipase C activity independently of their role as Ca2+ chelators[1][2].
(4-Acetyl-3,5-dihydroxy-phenyl)-(O2-alpha-L-rhamnopyranosyl-beta-D-glucopyranosid)|(4-acetyl-3,5-dihydroxy-phenyl)-(O2-alpha-L-rhamnopyranosyl-beta-D-glucopyranoside)|2,6-dihydroxy-4-(beta-neohesperidosyloxy)acetophenone|4beta-Neohesperidosyl-phloracetophenon|beta-Neohesperidosyl-4-phloracetophenon|Phloroacetophenone 4-O-beta-neohesperidoside|phloroacetophenone 4-neohesperidoside
(4-Acetyl-3,5-dihydroxy-phenyl)-(O2-alpha-L-rhamnopyranosyl-beta-D-glucopyranosid)|(4-acetyl-3,5-dihydroxy-phenyl)-(O2-alpha-L-rhamnopyranosyl-beta-D-glucopyranoside)|2,6-dihydroxy-4-(beta-neohesperidosyloxy)acetophenone|4beta-Neohesperidosyl-phloracetophenon|beta-Neohesperidosyl-4-phloracetophenon|Phloroacetophenone 4-O-beta-neohesperidoside|phloroacetophenone 4-neohesperidoside
arabitol-5-O-(6-O-trans-caffeoyl)-beta-D-glucopyranoside
arabitol-5-O-(6-O-trans-caffeoyl)-beta-D-glucopyranoside
5-Methoxy-2-beta-primverosyloxy-benzoesaeure-methylester|5-methoxy-2-beta-primverosyloxy-benzoic acid methyl ester
5-Methoxy-2-beta-primverosyloxy-benzoesaeure-methylester|5-methoxy-2-beta-primverosyloxy-benzoic acid methyl ester
4-O-beta-D-apifuranosyl-(1->2)-beta-D-glucopyranosyl-2-hydroxy-6-methoxyacetophenone
4-O-beta-D-apifuranosyl-(1->2)-beta-D-glucopyranosyl-2-hydroxy-6-methoxyacetophenone
(2R,3R)-6-[1-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-yl]pinobanksin 3-acetate
(2R,3R)-6-[1-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-yl]pinobanksin 3-acetate
(2R)-(6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyloxy)-phenylacetic acid|(2R)-(6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyloxy)phenylacetic acid|amygdalinic acid|mandelic acid beta-gentiobioside
(2R)-(6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyloxy)-phenylacetic acid|(2R)-(6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyloxy)phenylacetic acid|amygdalinic acid|mandelic acid beta-gentiobioside
(10S)-10-C-(4-O-benzoyl-alpha-arabinopyranosyl)-1,8-dihydroxy-3-methylanthracen-9(10H)-one|picramnioside G
(10S)-10-C-(4-O-benzoyl-alpha-arabinopyranosyl)-1,8-dihydroxy-3-methylanthracen-9(10H)-one|picramnioside G
Flunarizine 2HCl
Flunarizine hydrochloride
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Flunarizine dihydrochloride is a potent dual Na+/Ca2+ channel (T-type) blocker. Flunarizine dihydrochloride is a D2 dopamine receptor antagonist. Flunarizine dihydrochloride shows anticonvulsive and antimigraine activity, and peripheral vasodilator effects[1][2][3][4][5].
methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate
NCGC00385068-01!methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate
C20H28O13_Benzoic acid, 4-methoxy-2-[(6-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy]-, methyl ester
NCGC00385068-02_C20H28O13_Benzoic acid, 4-methoxy-2-[(6-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy]-, methyl ester
methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate [IIN-based on: CCMSLIB00000848774]
NCGC00385068-01!methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate [IIN-based on: CCMSLIB00000848774]
methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate [IIN-based: Match]
NCGC00385068-01!methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate [IIN-based: Match]
Cys Glu Glu Pro
(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carboxybutanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid
Cys Glu Pro Glu
(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carboxybutanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid
Cys His Met Ser
(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanoic acid
Cys His Ser Met
(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanoic acid
Cys Met His Ser
(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid
Cys Met Ser His
(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid
Cys Pro Glu Glu
(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-4-carboxybutanamido]pentanedioic acid
Cys Ser His Met
(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanoic acid
Cys Ser Met His
(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanoic acid
Asp Asp Met Pro
(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid
Asp Asp Asn Asn
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid
Asp Asp Pro Met
(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-4-[(2S)-2-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid
Asp Met Asp Pro
(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-(methylsulfanyl)butanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid
Asp Met Pro Asp
(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}butanedioic acid
Asp Asn Asp Asn
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-3-carboxypropanamido]-3-carbamoylpropanoic acid
Asp Asn Asn Asp
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]butanedioic acid
Asp Pro Asp Met
(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]-4-(methylsulfanyl)butanoic acid
Asp Pro Met Asp
(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]butanedioic acid
Glu Cys Glu Pro
(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carboxybutanamido]-3-sulfanylpropanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid
Glu Cys Pro Glu
(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-4-carboxybutanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid
Glu Glu Cys Pro
(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carboxybutanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid
Glu Glu Pro Cys
(4S)-4-[(2S)-2-amino-4-carboxybutanamido]-5-[(2S)-2-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid
Glu Pro Cys Glu
(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-4-carboxybutanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]pentanedioic acid
Glu Pro Glu Cys
(4S)-4-{[(2S)-1-[(2S)-2-amino-4-carboxybutanoyl]pyrrolidin-2-yl]formamido}-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid
His Cys Met Ser
(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanoic acid
His Cys Ser Met
(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanoic acid
His Met Cys Ser
(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid
His Met Ser Cys
(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid
His Ser Cys Met
(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid
His Ser Met Cys
(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid
Met Cys His Ser
(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid
Met Cys Ser His
(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid
Met Asp Asp Pro
(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carboxypropanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid
Met Asp Pro Asp
(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}butanedioic acid
Met His Cys Ser
(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid
Met His Ser Cys
(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid
Met Pro Asp Asp
(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]butanedioic acid
Met Ser Cys His
(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid
Met Ser His Cys
(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid
Asn Asp Asp Asn
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-3-carboxypropanamido]-3-carbamoylpropanoic acid
Asn Asp Asn Asp
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-3-carbamoylpropanamido]butanedioic acid
Asn Asn Asp Asp
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-carboxypropanamido]butanedioic acid
Pro Cys Glu Glu
(2S)-2-[(2S)-4-carboxy-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]butanamido]pentanedioic acid
Pro Asp Asp Met
(2S)-2-[(2S)-3-carboxy-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]-4-(methylsulfanyl)butanoic acid
Pro Asp Met Asp
(2S)-2-[(2S)-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-(methylsulfanyl)butanamido]butanedioic acid
Pro Glu Cys Glu
(2S)-2-[(2R)-2-[(2S)-4-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-sulfanylpropanamido]pentanedioic acid
Pro Glu Glu Cys
(4S)-4-{[(1S)-3-carboxy-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid
Pro Met Asp Asp
(2S)-2-[(2S)-3-carboxy-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]butanedioic acid
Ser Cys His Met
(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanoic acid
Ser Cys Met His
(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanoic acid
Ser His Cys Met
(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid
Ser His Met Cys
(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid
Ser Met Cys His
(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid
Ser Met His Cys
(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid
Feclobuzone
Feclobuzone
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
Methotrexate sodium
Sodium (S)-4-carboxy-2-(4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)butanoate
D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents
2-Ethoxybenzoic acid [5-methyl-4-(4-methylphenyl)sulfonyl-2-phenyl-3-pyrazolyl] ester
2-Ethoxybenzoic acid [5-methyl-4-(4-methylphenyl)sulfonyl-2-phenyl-3-pyrazolyl] ester
2-{5-[3-(7-Propyl-3-trifluoromethylbenzo[D]isoxazol-6-yloxy)propoxy]indol-1-YL}ethanoic acid
2-{5-[3-(7-Propyl-3-trifluoromethylbenzo[D]isoxazol-6-yloxy)propoxy]indol-1-YL}ethanoic acid
N-(Cyclopropylmethyl)-4-(methyloxy)-3-({5-[3-(3-pyridinyl)phenyl]-1,3-oxazol-2-YL}amino)benzenesulfonamide
N-(Cyclopropylmethyl)-4-(methyloxy)-3-({5-[3-(3-pyridinyl)phenyl]-1,3-oxazol-2-YL}amino)benzenesulfonamide
(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester
(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester
Temocapril
Temocapril
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
4-[(3aR,4S,9bS)-8-[(4-methoxyphenyl)sulfamoyl]-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-4-yl]benzoic acid
4-[(3aR,4S,9bS)-8-[(4-methoxyphenyl)sulfamoyl]-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-4-yl]benzoic acid
methyl 5-bromo-3-[[2-(4-cyclohexylpiperazin-1-yl)acetyl]amino]-1H-indole-2-carboxylate
methyl 5-bromo-3-[[2-(4-cyclohexylpiperazin-1-yl)acetyl]amino]-1H-indole-2-carboxylate
Guangsangon L
Guangsangon L
A member of the class of polyphenols consisting of a methylcyclohexene ring attached to a 2,4-dihydroxyphenyl, 2,4-dihydroxybenzoyl and 2,4-dihydroxybenzaldehyde moieties at positions 5, 4 and 3 respectively. Regarded biogenetically as a Diels-Alder adduct, it is isolated from the stem barks of Morus macroura and exhibits antioxidant activity.
N-(2,4-dimethoxyphenyl)-3-[[2-(2-methoxyphenoxy)-1-oxoethyl]amino]-2-benzofurancarboxamide
N-(2,4-dimethoxyphenyl)-3-[[2-(2-methoxyphenoxy)-1-oxoethyl]amino]-2-benzofurancarboxamide
2-(2-Naphthalenylsulfonylamino)acetic acid [2-(2,5-dimethyl-1-phenyl-3-pyrrolyl)-2-oxoethyl] ester
2-(2-Naphthalenylsulfonylamino)acetic acid [2-(2,5-dimethyl-1-phenyl-3-pyrrolyl)-2-oxoethyl] ester
methyl 2-[(3-amino-4-carbamoyl-5-cyclohexylimino-2H-thiophene-2-carbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
methyl 2-[(3-amino-4-carbamoyl-5-cyclohexylimino-2H-thiophene-2-carbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
(2S,3S,3aR,9bR)-1-acetyl-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3S,3aR,9bR)-1-acetyl-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-1-acetyl-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-1-acetyl-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
[(3aR,4R,9bR)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aR,4R,9bR)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aS,4R,9bS)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aS,4R,9bS)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aS,4S,9bS)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aS,4S,9bS)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aR,4S,9bR)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aR,4S,9bR)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
(4S,4aR,5R,5aR,6S,11aS,12aR)-4-(dimethylamino)-1,5,6,10,11a,12a-hexahydroxy-6-methyl-3,11,12-trioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
(4S,4aR,5R,5aR,6S,11aS,12aR)-4-(dimethylamino)-1,5,6,10,11a,12a-hexahydroxy-6-methyl-3,11,12-trioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
BAPTA
BAPTA
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D064449 - Sequestering Agents > D002614 - Chelating Agents BAPTA is a selective chelator for calcium. BAPTA, as calcium indicator, has high selectivity against magnesium and calcium. BAPTA is widely used as an intracellular buffer for investigating the effects of Ca2+ release from intracellular stores or influx via Ca2+-permeable channels in the plasma membrane. BAPTA can also inhibit phospholipase C activity independently of their role as Ca2+ chelators[1][2].
5-[6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxybenzaldehyde
5-[6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxybenzaldehyde
(2r,3s)-2,3-dihydroxy-4-{[2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoyl]oxy}butyl 2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoate
(2r,3s)-2,3-dihydroxy-4-{[2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoyl]oxy}butyl 2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoate
4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-3-methoxybenzoic acid
4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-3-methoxybenzoic acid
5-[(1s,5r,6r)-6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxybenzaldehyde
5-[(1s,5r,6r)-6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxybenzaldehyde
(2R,3 R)-6［1-(4'-hydroxy-3'-methoxyphenyl)prop-2en-1-yl］-pinobanksin-3-acetate
NA
{"Ingredient_id": "HBIN006448","Ingredient_name": "(2R,3 R)-6\uff3b1-(4'-hydroxy-3'-methoxyphenyl)prop-2en-1-yl\uff3d-pinobanksin-3-acetate","Alias": "NA","Ingredient_formula": "C27H24O8","Ingredient_Smile": "CC(=O)OC1C(OC2=CC(=C(C(=C2C1=O)O)C(C=C)C3=CC(=C(C=C3)O)OC)O)C4=CC=CC=C4","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41730","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-hydroxy-2,5-bis(hydroxymethyl)-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-3-yl 4-methoxybenzoate
4-hydroxy-2,5-bis(hydroxymethyl)-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-3-yl 4-methoxybenzoate
4-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3-methoxybenzoic acid
4-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3-methoxybenzoic acid
(3r,4s,5s,6r)-6-[(9s)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-4,5-dihydroxyoxan-3-yl benzoate
(3r,4s,5s,6r)-6-[(9s)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-4,5-dihydroxyoxan-3-yl benzoate
(2r,3s)-2,3-dihydroxy-4-{[(2e)-2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoyl]oxy}butyl (2z)-2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoate
(2r,3s)-2,3-dihydroxy-4-{[(2e)-2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoyl]oxy}butyl (2z)-2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoate
(1r,2s,5r,6s,14s,17s,18s)-10-{[(2r)-2-carboxy-2-hydroxyethyl]sulfanyl}-17-methyl-9,12-dioxo-15-oxapentacyclo[12.6.0.0¹,⁶.0²,¹⁸.0⁸,¹³]icosa-8(13),10-diene-5-carboxylic acid
(1r,2s,5r,6s,14s,17s,18s)-10-{[(2r)-2-carboxy-2-hydroxyethyl]sulfanyl}-17-methyl-9,12-dioxo-15-oxapentacyclo[12.6.0.0¹,⁶.0²,¹⁸.0⁸,¹³]icosa-8(13),10-diene-5-carboxylic acid
(r)-phenyl({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy})acetic acid
(r)-phenyl({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy})acetic acid
2,3-dihydroxy-4-{[2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoyl]oxy}butyl 2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoate
2,3-dihydroxy-4-{[2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoyl]oxy}butyl 2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoate
1-(4-{[(2s,3r,4s,5s,6r)-3-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxy-6-methoxyphenyl)ethanone
1-(4-{[(2s,3r,4s,5s,6r)-3-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxy-6-methoxyphenyl)ethanone
(2r,3s)-2,3-dihydroxy-4-{[(2e)-2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoyl]oxy}butyl (2e)-2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoate
(2r,3s)-2,3-dihydroxy-4-{[(2e)-2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoyl]oxy}butyl (2e)-2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoate
(2s,3s,4r,5r)-4-hydroxy-2,5-bis(hydroxymethyl)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-3-yl 4-methoxybenzoate
(2s,3s,4r,5r)-4-hydroxy-2,5-bis(hydroxymethyl)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-3-yl 4-methoxybenzoate
1-(4-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2,6-dihydroxyphenyl)ethanone
1-(4-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2,6-dihydroxyphenyl)ethanone
1-(4-{[(2s,3r,4s,5r,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-2-hydroxy-6-methoxyphenyl)ethanone
1-(4-{[(2s,3r,4s,5r,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-2-hydroxy-6-methoxyphenyl)ethanone
6-(4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl)-4,5-dihydroxyoxan-3-yl benzoate
6-(4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl)-4,5-dihydroxyoxan-3-yl benzoate
(3r,4s,5s,6r)-6-[(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-4,5-dihydroxyoxan-3-yl benzoate
(3r,4s,5s,6r)-6-[(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-4,5-dihydroxyoxan-3-yl benzoate
10-[(2-carboxy-2-hydroxyethyl)sulfanyl]-17-methyl-9,12-dioxo-15-oxapentacyclo[12.6.0.0¹,⁶.0²,¹⁸.0⁸,¹³]icosa-8(13),10-diene-5-carboxylic acid
10-[(2-carboxy-2-hydroxyethyl)sulfanyl]-17-methyl-9,12-dioxo-15-oxapentacyclo[12.6.0.0¹,⁶.0²,¹⁸.0⁸,¹³]icosa-8(13),10-diene-5-carboxylic acid
phenyl({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy})acetic acid
phenyl({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy})acetic acid
1-(4-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-2-hydroxy-6-methoxyphenyl)ethanone
1-(4-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-2-hydroxy-6-methoxyphenyl)ethanone
methyl 2-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}benzoate
methyl 2-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}benzoate
1-(4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-2,6-dihydroxyphenyl)ethanone
1-(4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-2,6-dihydroxyphenyl)ethanone
